Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing
Year: 2017
Type: article
Source: Biomaterials
Authors: Piul S. Rabbani, Anna Zhou, Zachary M. Borab, Joseph A. Frezzo, Nikita Srivastava, Haresh T. More, William J. Rifkin, Joshua A. David, Samuel J. Berens, Raymond Chen, Sophia Hameedi, Muhammad H. Junejo, Camille Kim, Rita A. Sartor, Che F. Liu, Pierre B. Saadeh, Jin K. Montclare, Daniel J. Ceradini
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: National Science Foundation, American Diabetes Association, New York University, NYU Langone Medical Center, Church and Dwight, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences, Office of Research Infrastructure Programs, National Institutes of Health
Awards: G15585836, Sandy Recovery Ventana Medical Systems Discovery XT, G2412840553, G2653646949, Therapeutically Targeting Keap1/Nrf2 Dysfunciton in Diabetes, Engineered Protein-Lipid Systems for siRNA and Small Molecule Delivery, Institutional Clinical and Translational Science Award, G5946519234, Cancer Center Support Grant
OpenAlex ID: W2604739897
